GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Oracle Healthcare Acquisition Corp (OTCPK:OHAQ) » Definitions » ROE %

Oracle Healthcare Acquisition (Oracle Healthcare Acquisition) ROE % : -33.06% (As of Dec. 2007)


View and export this data going back to 2006. Start your Free Trial

What is Oracle Healthcare Acquisition ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Oracle Healthcare Acquisition's annualized net income for the quarter that ended in Dec. 2007 was $-28.69 Mil. Oracle Healthcare Acquisition's average Total Stockholders Equity over the quarter that ended in Dec. 2007 was $86.78 Mil. Therefore, Oracle Healthcare Acquisition's annualized ROE % for the quarter that ended in Dec. 2007 was -33.06%.

The historical rank and industry rank for Oracle Healthcare Acquisition's ROE % or its related term are showing as below:

OHAQ's ROE % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 4.13
* Ranked among companies with meaningful ROE % only.

Oracle Healthcare Acquisition ROE % Historical Data

The historical data trend for Oracle Healthcare Acquisition's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oracle Healthcare Acquisition ROE % Chart

Oracle Healthcare Acquisition Annual Data
Trend Dec05 Dec06 Dec07
ROE %
- 18.10 9.29

Oracle Healthcare Acquisition Quarterly Data
Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07
ROE % Get a 7-Day Free Trial 0.61 11.86 10.66 47.57 -33.06

Competitive Comparison of Oracle Healthcare Acquisition's ROE %

For the Medical Care Facilities subindustry, Oracle Healthcare Acquisition's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oracle Healthcare Acquisition's ROE % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Oracle Healthcare Acquisition's ROE % distribution charts can be found below:

* The bar in red indicates where Oracle Healthcare Acquisition's ROE % falls into.



Oracle Healthcare Acquisition ROE % Calculation

Oracle Healthcare Acquisition's annualized ROE % for the fiscal year that ended in Dec. 2007 is calculated as

ROE %=Net Income (A: Dec. 2007 )/( (Total Stockholders Equity (A: Dec. 2006 )+Total Stockholders Equity (A: Dec. 2007 ))/ count )
=7.407/( (76.405+83.118)/ 2 )
=7.407/79.7615
=9.29 %

Oracle Healthcare Acquisition's annualized ROE % for the quarter that ended in Dec. 2007 is calculated as

ROE %=Net Income (Q: Dec. 2007 )/( (Total Stockholders Equity (Q: Sep. 2007 )+Total Stockholders Equity (Q: Dec. 2007 ))/ count )
=-28.688/( (90.445+83.118)/ 2 )
=-28.688/86.7815
=-33.06 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2007) net income data. ROE % is displayed in the 30-year financial page.


Oracle Healthcare Acquisition  (OTCPK:OHAQ) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2007 )
=Net Income/Total Stockholders Equity
=-28.688/86.7815
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-28.688 / 0)*(0 / 120.0445)*(120.0445 / 86.7815)
=Net Margin %*Asset Turnover*Equity Multiplier
=N/A %*0*1.3833
=ROA %*Equity Multiplier
=N/A %*1.3833
=-33.06 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2007 )
=Net Income/Total Stockholders Equity
=-28.688/86.7815
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-28.688 / -25.824) * (-25.824 / 22.492) * (22.492 / 0) * (0 / 120.0445) * (120.0445 / 86.7815)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1.1109 * -1.1481 * N/A % * 0 * 1.3833
=-33.06 %

Note: The net income data used here is four times the quarterly (Dec. 2007) net income data. The Revenue data used here is four times the quarterly (Dec. 2007) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Oracle Healthcare Acquisition ROE % Related Terms

Thank you for viewing the detailed overview of Oracle Healthcare Acquisition's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Oracle Healthcare Acquisition (Oracle Healthcare Acquisition) Business Description

Traded in Other Exchanges
N/A
Address
Website
Executives
Andrew M Weiss 10 percent owner 222 BERKELEY STREET, 16TH FLOOR, BOSTON MA 02116
Jeffrey Tannenbaum 10 percent owner 505 FIFTH AVENUE, 23RD FLOOR, NEW YORK NY 10017
Fir Tree Inc. 10 percent owner 500 FIFTH AVENUE, 9TH FLOOR, NEW YORK NY 10110
Camellia Partners, Llc 10 percent owner 51 BEDFORD ROAD, SUITES 3 & 4, KATONAH NY 10536
Andrew Fredman 10 percent owner 7301 SW 57TH COURT, SUITE 410, SOUTH MIAMI FL 33143
Fir Tree, L.l.c. 10 percent owner 505 FIFTH AVENUE, 23RD FLOOR, NEW YORK NY 10017
Per Gh Lofberg director C/O MERCK CAPITAL VENTURES, 50 TICE BLVD, WOODCLIFF NJ 07677
Larry N Feinberg director, 10 percent owner C/O ORACLE PARTNERS L P, 200 GREENWICH AVENUE, GREENWICH CT 06830
George Bickerstaff director C/O VION PHARMACEUTICALS, INC., 4 SCIENCE PARK, NEW HAVEN CT 06511
Kevin C Johnson director 12 KEELERS RIDGE ROAD, WILTON CT 06897
Mark A Radzik officer: CFO & Secretary
Joel D Liffman director, officer: President and COO C/O ORACLE STRATEGIES PARTNERS, L.P., 712 FIFTH AVENUE, 45TH FLOOR, NEW YORK NY 10019

Oracle Healthcare Acquisition (Oracle Healthcare Acquisition) Headlines

No Headlines